Topic Overview
What is a slipped capital femoral epiphysis?
A slipped capital femoral epiphysis occurs when the upper end of
the thigh bone (femur) slips at the area where the bone is growing (growth
plate or physis) and does not fit in the hip socket correctly. The condition is
most common in teenagers.
What causes a slipped capital femoral epiphysis?
Rapid growth and an imbalance of hormones during adolescence may
cause a slipped capital femoral epiphysis. An injury or a rapid increase in
body weight or height may trigger symptoms.
What are the symptoms?
Symptoms usually begin between 8 and 16 years of age, and they
may begin earlier in girls than in boys. Symptoms vary in severity and speed of
progression. Symptoms may include:
- Hip tenderness and decreased movement during
the early stages of the condition.
- Increased pain when the toes are
turned in toward midline (internal rotation of the hip).
- Mild
discomfort in the groin, thigh, or knee while walking or running. Rest relieves
this discomfort.
- Knee pain.
- Stiffness and a limp,
especially when tired.
- Muscle spasms.
- Mild to severe
pain.
How is a slipped capital femoral epiphysis diagnosed?
Your health professional will conduct a physical exam to identify
your symptoms and a medical history to learn how long you have had your
symptoms.
X-rays and sometimes
CT scan or
MRI are used to confirm a diagnosis of slipped capital
femoral epiphysis.
How is it treated?
The goal of treatment for a slipped capital femoral epiphysis is
to prevent further slippage and reduce complications of the condition. This
often involves surgery to secure the growth plate (physis) with a single screw
or with pins.
A slipped capital femoral epiphysis may lead to early
degenerative arthritis of the hip if not detected early and treated
properly.
Who is affected by a slipped capital femoral epiphysis?
A slipped capital femoral epiphysis is the most common serious
hip condition seen in teenagers, more common in boys than in girls, and more
common in very overweight teenagers. The condition most commonly affects young
adolescents, ages 11 to 14 years old.